Anzeige
Mehr »
Login
Montag, 20.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
100-Milliarden-Dollar-Marke: Wie die strategische Vision eines Unternehmens historischem Meilenstein passt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
822 Leser
Artikel bewerten:
(2)

FUJIFILM Europe GmbH: Fujifilm Europe supports World Cancer Day

Finanznachrichten News

RATINGEN, Germany, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Fujifilm Europe has announced its partnership with World Cancer Day, an initiative led by the Union for International Cancer Control (UICC), the largest and oldest international cancer organisation dedicated to taking the lead in convening, capacity building and advocacy initiatives that unite the cancer community to reduce the global cancer burden, promote greater equity, and integrate cancer control into the world health and development agenda.

The day takes place on the 4th of February each year, and aims to raise awareness and improve education about cancer, as well as encourage governments to take action against the disease.

This year's theme is 'closing the care gap', and focuses on the lack of accessibility to health services faced by many people around the world. Half the world's population lacks access to the full range of essential health services. When it comes to cancer, many people are denied basic care, despite the fact that we live in a time of awe-inspiring advancements in cancer prevention, diagnosis and treatment.

Fujifilm is committed to achieving universal health coverage, ensuring that everyone can access essential medical services. This extends not only to regions with less developed medical infrastructures, but also to advanced countries. To this end, Fujifilm's devices have long supported healthcare professionals in making prompt and accurate diagnoses. The company continually develops novel devices, upgrades its technologies and harnesses advanced AI algorithms to make screening more accessible around the world.

These solutions extend to cancer prevention, screening and diagnosis, where they help to identify diseases at an early stage. Toshihisa Iida, President and Managing Director at FUJIFILM Europe GmbH, commented: "We are extremely proud to be a partner of World Cancer Day, and to show our dedication to advancing the fight against cancer. We believe access to medical care should be equal for all, and this can only be achieved by removing the geographical and economic barriers that block the latest innovations from reaching many patients. Although this is a difficult task, there is progress, and we will continue to support initiatives like this to work towards our vision for a healthier world."

Dr Cary Adams, CEO of the Union for International Cancer Control
"As individuals, as communities, we can and must come together and break down barriers. We have achieved a lot in the last decade in cancer care and control around the world but not addressing inequities in society is slowing our progress. Closing the care gap is about fairness, dignity and fundamental rights to allow everyone to lead longer lives in better health."

Read more about Fujifilm here fujifilm.com/uk/en/neverstop/worldcancerday

About FUJIFILM Europe GmbH

Fujifilm operates over 50 group companies and branches in Europe and employs more than 6000 people engaged in R&D, manufacturing, sales and service, with FUJIFILM Europe GmbH, located in Ratingen, Germany, operating as the strategic headquarters for the region. Throughout Europe, Fujifilm entities serve a range of industries including medical technology, biopharmaceuticals, electronic materials, industrial products, chemicals, graphic systems, optical devices, data storage and all aspects of photography. Over the last 20 years, the company has more intensively focused on healthcare - from diagnosis to prevention and treatment. Today, Fujifilm in Europe provides the entire spectrum of patient care, in addition to research, development and CDMO manufacturing in advanced therapies, gene therapies and vaccines, as well as providing cell culture media and regenerative medicine solutions.
For more information, please visit: fujifilm.com

About World Cancer Day
World Cancer Day on 4 February is a uniting global initiative spearheaded by the Union for International Cancer Control (UICC) to raise awareness and improve education about the disease, while calling for action from governments and individuals across the world.

Luana Porfido
Head of Corporate Communications - Europe
FUJIFILM Europe GmbH
luana.porfido@fujifilm.com
+39 (0)3459529101

Andy Ross
Deputy Head of Corporate Communications - Europe
FUJIFILM Europe GmbH
andy.jm.ross@fujifilm.com
+44 (0)7766497949

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a3984b37-4f77-487b-a13d-89d77cd06530


© 2023 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.